14 GENES FOUND
Show / hide columns
XML |
RDF |
TSV |
Page
of 1
CRP C-reactive protein, pentraxin-related Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins Group enriched gallbladder: 173.7 liver: 532.4
HABP2 Hyaluronan binding protein 2 Candidate cardiovascular disease genes Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins Group enriched gallbladder: 56.0 liver: 225.6
ABCC2 ATP-binding cassette, sub-family C (CFTR/MRP), member 2 Cancer-related genes Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Group enriched duodenum: 44.7 gallbladder: 42.8 kidney: 20.8 liver: 67.6 small intestine: 50.5
AKR1C2 Aldo-keto reductase family 1, member C2 Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins Nucleus Nucleoli fibrillar center Endoplasmic reticulum Cytosol Group enriched adipose tissue: 352.3 breast: 122.0 esophagus: 118.4 gallbladder: 189.9 liver: 186.5 stomach: 138.5 urinary bladder: 186.3
CES1 Carboxylesterase 1 Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted secreted proteins Endoplasmic reticulum Group enriched gallbladder: 400.5 liver: 1099.6 lung: 229.6
CLRN3 Clarin 3 Predicted membrane proteins Transporters Group enriched colon: 71.2 duodenum: 75.4 gallbladder: 23.7 kidney: 43.9 liver: 40.2 rectum: 77.5 small intestine: 99.5
CYP2C18 Cytochrome P450, family 2, subfamily C, polypeptide 18 Enzymes Plasma proteins Predicted secreted proteins Group enriched duodenum: 105.9 esophagus: 24.7 gallbladder: 24.5 liver: 97.7 small intestine: 90.0 stomach: 62.7
F5 Coagulation factor V (proaccelerin, labile factor) Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins Golgi apparatus Group enriched gallbladder: 28.5 liver: 93.7 placenta: 67.7
NR1I2 Nuclear receptor subfamily 1, group I, member 2 FDA approved drug targets Nuclear receptors Plasma proteins Predicted intracellular proteins Transcription factors Nucleoplasm Group enriched colon: 9.3 duodenum: 23.2 gallbladder: 6.0 liver: 19.7 rectum: 9.4 small intestine: 26.3
ONECUT1 One cut homeobox 1 Predicted intracellular proteins Transcription factors Group enriched gallbladder: 8.5 liver: 5.9 pancreas: 2.3 testis: 1.8
SLC17A4 Solute carrier family 17, member 4 Predicted membrane proteins Transporters Group enriched colon: 20.8 duodenum: 29.4 gallbladder: 25.5 liver: 22.4 rectum: 29.4 small intestine: 35.7
TM4SF4 Transmembrane 4 L six family member 4 Predicted membrane proteins Transporters Plasma membrane Cytosol Group enriched duodenum: 595.8 gallbladder: 1326.5 liver: 343.7 small intestine: 515.2
UGT2B15 UDP glucuronosyltransferase 2 family, polypeptide B15 Enzymes Predicted membrane proteins Group enriched colon: 23.8 duodenum: 30.6 gallbladder: 114.5 liver: 108.6 small intestine: 33.9
VNN1 Vanin 1 Enzymes Plasma proteins Predicted secreted proteins Group enriched duodenum: 176.1 gallbladder: 175.5 liver: 142.6 small intestine: 108.8
Page
of 1